Growth Metrics

Conmed (CNMD) Non-Current Debt (2016 - 2026)

Conmed filings provide 17 years of Non-Current Debt readings, the most recent being $860.2 million for Q1 2026.

  • On a quarterly basis, Non-Current Debt fell 3.51% to $860.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $860.2 million, a 3.51% decrease, with the full-year FY2025 number at $834.2 million, down 7.83% from a year prior.
  • Non-Current Debt hit $860.2 million in Q1 2026 for Conmed, up from $834.2 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $1.0 billion in Q3 2022 to a low of $703.5 million in Q1 2022.
  • Median Non-Current Debt over the past 5 years was $942.2 million (2023), compared with a mean of $924.1 million.
  • Biggest five-year swings in Non-Current Debt: skyrocketed 47.36% in 2022 and later decreased 9.97% in 2025.
  • Conmed's Non-Current Debt stood at $985.1 million in 2022, then dropped by 1.21% to $973.1 million in 2023, then dropped by 7.0% to $905.1 million in 2024, then fell by 7.83% to $834.2 million in 2025, then rose by 3.11% to $860.2 million in 2026.
  • The last three reported values for Non-Current Debt were $860.2 million (Q1 2026), $834.2 million (Q4 2025), and $853.0 million (Q3 2025) per Business Quant data.